Keros Therapeutics, Inc. Quarterly Other Assets, Current in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Keros Therapeutics, Inc. quarterly Other Assets, Current history and growth rate from Q4 2019 to Q2 2024.
  • Keros Therapeutics, Inc. Other Assets, Current for the quarter ending June 30, 2024 was $582K, a 54.8% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $582K +$206K +54.8% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $616K +$101K +19.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1M +$725K +263% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 $319K -$426K -57.2% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $376K -$90K -19.3% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $515K +$264K +105% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $276K +$66K +31.4% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $745K +$432K +138% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $466K +$176K +60.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $251K -$14K -5.28% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $210K +$50K +31.3% Dec 31, 2021 10-K 2023-03-03
Q3 2021 $313K +$183K +141% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $290K +$11K +3.94% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $265K -$70K -20.9% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $160K -$55K -25.6% Dec 31, 2020 10-K 2022-03-09
Q3 2020 $130K Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $279K Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $335K Mar 31, 2020 10-Q 2020-05-22
Q4 2019 $215K Dec 31, 2019 10-K 2021-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.